These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Intracellular and serum levels of aldolase activity in B chronic lymphocytic leukemia. Musolino C; Alonci A; Allegra A; Di Cesare E; Orlando A; Grosso P; Buda G; Squadrito G Int J Hematol; 1992 Dec; 56(3):213-7. PubMed ID: 1477333 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity. Cordone I; Matutes E; Catovsky D Leukemia; 1992 Sep; 6(9):902-6. PubMed ID: 1387694 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of proliferating cell nuclear antigen expression in chronic lymphoid leukemia. del Giglio A; O'Brien S; Ford R; Saya H; Manning J; Keating M; Johnston D; Khetan R; el-Naggar A; Deisseroth A Blood; 1992 May; 79(10):2717-20. PubMed ID: 1350226 [TBL] [Abstract][Full Text] [Related]
11. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia. Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902 [TBL] [Abstract][Full Text] [Related]
12. Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia. Romano C; Sellitto A; Chiurazzi F; Simeone L; De Fanis U; Raia M; Del Vecchio L; Lucivero G Int J Hematol; 2015 Jan; 101(1):67-74. PubMed ID: 25432435 [TBL] [Abstract][Full Text] [Related]
13. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells. Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151 [TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic and DNA genotypic analysis of T-cell and NK-cell subpopulations in patients with B-cell chronic lymphocytic leukaemia (B-CLL). Frolova EA; Richards SJ; Jones RA; Rawstron A; Master PS; Teasdale J; Short M; Jack AS; Scott CS Leuk Lymphoma; 1995 Jan; 16(3-4):307-18. PubMed ID: 7719238 [TBL] [Abstract][Full Text] [Related]
15. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment. Kusenda J; Babusíková O Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418 [TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen (PCNA) expression in chronic lymphocytic leukemia (CLL). Del Giglio A; O'Brien S; Ford RJ; Manning J; Saya H; Keating M; Johnston D; Chamone DF; Deisseroth AB Leuk Lymphoma; 1993 Jul; 10(4-5):265-71. PubMed ID: 8106065 [TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression. Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522 [TBL] [Abstract][Full Text] [Related]
20. Differences in constitutive and activation-induced expression of CD69 and CD95 between normal and chronic lymphocytic leukemia B cells. De Fanis U; Romano C; Dalla Mora L; Sellitto A; Guastafierro S; Tirelli A; Bresciano E; Giunta R; Lucivero G Oncol Rep; 2003; 10(3):653-8. PubMed ID: 12684639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]